检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵莹 陈龙华[1] ZHAO Ying;CHEN Longhua(CT Room,the First Affiliated Hospital of Nanyang Medical College,Nanyang 473000,China)
机构地区:[1]南阳医学高等专科学校第一附属医院CT室,河南南阳473000
出 处:《临床医学工程》2023年第3期313-314,共2页Clinical Medicine & Engineering
摘 要:目的探讨磁共振成像-扩散加权成像(MRI-DWI)预测宫颈癌患者无瘤生存期的模型。方法选取2018年3月至2021年10月我院收治的70例宫颈癌患者,均接受MRI及DWI扫描,分析二者参数预测宫颈癌患者无瘤生存的价值。结果随访12个月,52例(74.29%)患者无瘤生存。无瘤生存组ADC值高于死亡组,K^(trans)值低于死亡组(P<0.05)。ADC值、K^(trans)值、联合检测评估宫颈癌患者无瘤生存的AUC分别为0.742、0.823、0.936;联合检测评估宫颈癌患者无瘤生存的AUC高于ADC值、K^(trans)值(P<0.05)。结论MRI-DWI检测中ADC值、K^(trans)值可用于评估宫颈癌患者预后情况,利用二者构建模型预测宫颈癌患者无瘤生存的价值较高。Objective To explore magnetic resonance imaging diffusion-weighted imaging(MRI-DWI)predicting tumor free survival model for patients with cervical cancer.Methods 70 patients with cervical cancer admitted to our hospital from March 2018 to October 2021 were selected and given MRI and DWI scanning.The value of both parameters in predicting tumor free survival of patients with cervical cancer was analyzed.Results Following up for 12 months,52 cases(74.29%)of patients with cervical cancer had tumor free survival.ADC value of the tumor free survival group was higher than that of the death group,and K^(trans) value was lower than that of the death group(P<0.05).AUC of ADC value,K^(trans) value and combined detection for evaluating tumor free survival of patients with cervical cancer were 0.742,0.823 and 0.936 respectively.AUC of the combined detection for evaluating tumor free survival of patients with cervical cancer was higher than those of ADC value and K^(trans) value(P<0.05).Conclusions ADC value and K^(trans) value in MRI-DWI can be used to evaluate the prognosis of cervical cancer patients,and it is of higher value for the model to predict the tumor free survival of patients with cervical cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15